Skip to main content
. 2015 Dec 8;6:1368. doi: 10.3389/fmicb.2015.01368

FIGURE 9.

FIGURE 9

Assessment of immunomodulatory effect of bioactive fractions on murine macrophages. (A) Estimation of CD80 and CD86 expression. Peritoneal macrophages from different treatment groups were exposed to surface staining with antimouse-CD80-APC and antimouse-CD86-PeCy7 along with appropriate controls. Individual percentages of CD80 and CD86 positive cells for each group were deduced with the help of BD FACS DIVA software. ∗∗∗P < 0.001, ∗∗P < 0.01, P < 0.05, and ns = non-significant with respect to INF. (B) Assessment of in vivo NO production. Culture supernatants from splenocytes of all the experimental groups were isolated and incubated with equal volume of griess reagent for NO estimation as described in methodology section. ∗∗∗P < 0.001 and ns = non-significant with respect to INF.